.
Projects
Former Teams
CV
Professional experiences
Since 2017: Project & quality manager, Biomics, Institut Pasteur, Paris
2012: Project & quality manager, ICAreB, CRT, Institut Pasteur, Paris
2011 : Researcher & teacher, Université Paris-Descartes P5, Paris
2010: Researcher & teacher, ENS de Cachan
2007: Post-doctoral fellow, onco-hematology, Institut Cochin, Paris
2004: Ph.D., Pathogen-host interactions in onco-hematology, Université Paris-Diderot P7, Paris
2003: Ms.II, Blood cell biology, Institut d’hématologie, Hôp. Saint-Louis, Paris
Training
2021
Mind Mapping, Docendi
2020
Drawing data management plan, Institut Pasteur
Adapter sa communication, Cegos
2019
Communiquer efficacement avec son équipe et sa hiérarchie, Comundi compétences
Manager avec le DISC, Comundi compétences
Accompagner le changement, Cegos
RGPD, nouveau cadre juridique de l’UE, Comundi. Les bases de la métrologie, Association Française de Normalisation (AFNOR)
Métrologie, Association Française de Normalisation (AFNOR)
2018
Assertivité, affirmation de soi en entreprise, Docendi.
2017
Gestion du temps, Demos. Audit ISO9011, PréIso.
2016
Audit ISO9011, Inserm.
Système de management de la qualité ISO 9001: v2015, Sunnikan Consulting.
2015
Conduite de projets, Elegia. Développement personnel, Thalance.
2014
Gestion de projets, Elegia.
Formation à la norme NF S96-900, Infrastructrure BIOBANQUE, Inserm.
2013
Système de management de la qualité NF S96-900, 3CR,
Déclaration/autorisation des activités de conservation des éléments du corps humain, CODECOH, 3CR.
2012
DIU Clinical trial investigations, Université Pierre et Marie Curie P6, Paris
Publications
Download-
2021How Did Institut Pasteur’s NGS Core Facility, Biomics, Manage the Coronavirus Disease 2019 Crisis?, J Biomol Tech 2021 07; 32(2): 50-56.
-
2020The ICAReB Platform: A Human Biobank for the Institut Pasteur and Beyond, Open Journal of Bioresources. 2020; 7: 1.
-
2013Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives, Int J Mol Sci 2013 Oct;14(10):20508-42.
-
2013[STAT5, a new therapeutic target against the relapse of chronic myelogenous leukemia?], Med Sci (Paris) 2013 Aug-Sep;29(8-9):693-5.
-
2013Differential contributions of STAT5A and STAT5B to stress protection and tyrosine kinase inhibitor resistance of chronic myeloid leukemia stem/progenitor cells, Cancer Res. 2013 Apr;73(7):2052-8.
-
2011A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB, BMC Cell Biol. 2011 Apr;12:14.
-
2010STAT1-dependent IgG cell-surface expression in a human B cell line derived from a STAT1-deficient patient, J. Leukoc. Biol. 2010 Jun;87(6):1145-52.
-
2010STAT1 and pathogens, not a friendly relationship, Biochimie 2010 May;92(5):425-44.
-
2008Novel function of STAT1beta in B cells: induction of cell death by a mechanism different from that of STAT1alpha, J. Leukoc. Biol. 2008 Dec;84(6):1604-12.
-
2005Latent membrane protein 1 regulates STAT1 through NF-kappaB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells, J. Virol. 2005 Apr;79(8):4936-43.
-
+View full list of publications